CASSS – HOS
April 04-06, 2022
FUJIFILM Diosynth Biotechectnologies is delighted to be a sponsor at CASSS/HOS 2022 Virtual Symposium, April 4-6, 2022.
“Protein higher-order structure (HOS) and dynamics are essential to protein function. For protein-based therapeutic products, HOS is a critical quality attribute which needs to be monitored to ensure safety and efficacy of drug products. HOS can be monitored by a multitude of biophysical and structural characterization tools. The choice of the appropriate biophysical method and the method development and qualification strategies to characterize and control HOS at different stages of the product lifecycle are a matter of interest and debate for a wide range of audiences.”
Join Us April 5, 2022 at 15:30
Katherine Bowers, PhD, Senior Principal Scientist/Group Leader, Analytical and Formulation Development, FUJIFILM Diosynth Biotechnologies will be co-chairing along side other leading industry experts.
Session VI: Discovery and Candidate Selection
- Biophysical methods and the understanding of protein behavior is a critical part of biopharmaceutical development. The time to start implementing these tools is at the beginning when the molecules are being designed and refined. This session will present three biophysical tools or approaches that can successfully impact the design and selection of lead therapeutic candidates.